{"id":"glucocorticoid-combination-therapy","safety":{"commonSideEffects":[{"rate":null,"effect":"Immunosuppression / increased infection risk"},{"rate":null,"effect":"Hyperglycemia"},{"rate":null,"effect":"Osteoporosis"},{"rate":null,"effect":"Hypertension"},{"rate":null,"effect":"Mood disturbances"}]},"_chembl":{"chemblId":"CHEMBL1559","moleculeType":"Small molecule","molecularWeight":"479.15"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Glucocorticoids work by translocating to the nucleus and modulating gene expression of pro-inflammatory mediators, reducing production of cytokines like TNF-α, IL-6, and IL-8. The combination approach typically pairs glucocorticoids with other immunosuppressive or anti-inflammatory agents to enhance efficacy while potentially reducing steroid burden and adverse effects.","oneSentence":"Glucocorticoid combination therapy suppresses immune and inflammatory responses by binding to glucocorticoid receptors and modulating cytokine production and immune cell activation.","_ai_confidence":"low"},"_scrapedAt":"2026-03-27T23:31:15.932Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Inflammatory and autoimmune diseases (specific indications not detailed in available information)"}]},"trialDetails":[{"nctId":"NCT04322357","phase":"PHASE2","title":"Twice Weekly Steroids and Exercise as Therapy for DMD","status":"COMPLETED","sponsor":"University of Florida","startDate":"2020-07-30","conditions":"Duchenne Muscular Dystrophy (DMD)","enrollment":21},{"nctId":"NCT07340463","phase":"PHASE2","title":"The Efficacy and Safety of Biologics (Belimumab/ Telitacicept) Induction Therapy in Proliferative Lupus Nephritis Patients for 6 Months Compared With Mycophenolate Mofetil Treatment","status":"RECRUITING","sponsor":"Nanjing University School of Medicine","startDate":"2025-12-08","conditions":"Systemic Lupus Erythematosus (SLE), Lupus Nephritis (LN)","enrollment":50},{"nctId":"NCT07451665","phase":"PHASE4","title":"Efficacy and Safety of Vunakizumab and Ivarmacitinib in the Treatment of Active Takayasu's Arteritis","status":"NOT_YET_RECRUITING","sponsor":"Chinese SLE Treatment And Research Group","startDate":"2026-04-01","conditions":"Takayasu Arteritis (TAK)","enrollment":180},{"nctId":"NCT05726292","phase":"PHASE2","title":"A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer","status":"RECRUITING","sponsor":"University of Chicago","startDate":"2025-01-06","conditions":"Prostate Cancer, Prostate Adenocarcinoma","enrollment":90},{"nctId":"NCT05679401","phase":"PHASE3","title":"A Study With Imlifidase in Anti-GBM Disease","status":"TERMINATED","sponsor":"Hansa Biopharma AB","startDate":"2022-12-22","conditions":"Anti-Glomerular Basement Membrane Disease, Anti-Glomerular Basement Membrane Antibody Disease, Goodpasture Syndrome","enrollment":50},{"nctId":"NCT07406932","phase":"NA","title":"A Study on the Efficacy and Safety of JAK Inhibitors Versus Calcineurin Inhibitors as Initial Therapy for Interstitial Lung Disease Associated With Antisynthetase Syndrome","status":"NOT_YET_RECRUITING","sponsor":"China-Japan Friendship Hospital","startDate":"2026-02-01","conditions":"Antisynthetase Syndrome, Interstitial Lung Disease (ILD)","enrollment":80},{"nctId":"NCT07234019","phase":"PHASE2","title":"Rituximab Combining Anti-CD38 Monoclonal Antibody Versus Rituximab in the Management of Primary Immune Thrombocytopenia (ITP)","status":"RECRUITING","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2026-01-28","conditions":"Immune Thrombocytopenia, Treatment","enrollment":160},{"nctId":"NCT07382375","phase":"NA","title":"AI-assisted Subtyping-directed Precision Treatment in Acute Aortic Dissection","status":"NOT_YET_RECRUITING","sponsor":"Nanjing Medical University","startDate":"2027-12-31","conditions":"Aortic Aneurysm and Dissection","enrollment":300},{"nctId":"NCT07362667","phase":"","title":"A Study of the Efficacy and Safety of Bronchoscopic Airway Clearance and Amphotericin B Spraying in Patients With ABPA","status":"RECRUITING","sponsor":"Qianfoshan Hospital","startDate":"2026-01-10","conditions":"ABPA, Allergic Bronchopulmonary Aspergillosis, Allergic Bronchopulmonary Aspergillosis (ABPA)","enrollment":44},{"nctId":"NCT07362693","phase":"","title":"A Cohort Study of the Efficacy and Safety of Biologics in Patients With ABPA","status":"NOT_YET_RECRUITING","sponsor":"Qianfoshan Hospital","startDate":"2025-12-31","conditions":"ABPA, Biologics, Allergic Bronchopulmonary Aspergillosis (ABPA)","enrollment":50},{"nctId":"NCT07363733","phase":"NA","title":"Dynamic Quadripolar Radiofrequency VS Topical Corticosteroids in Women With Vulvar Lichen Sclerosus","status":"RECRUITING","sponsor":"Federal State Budget Institution Research Center for Obstetrics, Gynecology and Perinatology Ministry of Healthcare","startDate":"2026-01","conditions":"Vulvar Lichen Sclerosus","enrollment":68},{"nctId":"NCT07354503","phase":"","title":"Telitacicept in the Treatment of Pediatric IgA Vasculitis-Associated Nephritis","status":"NOT_YET_RECRUITING","sponsor":"The Children's Hospital of Zhejiang University School of Medicine","startDate":"2026-01-01","conditions":"IgAVN, IgA Vasculitis","enrollment":300},{"nctId":"NCT04951986","phase":"PHASE3","title":"Testing New Strategies for Patients Hospitalised With HIV-associated Disseminated Tuberculosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Cape Town","startDate":"2021-08-11","conditions":"Disseminated Tuberculosis, HIV","enrollment":732},{"nctId":"NCT05128942","phase":"PHASE2","title":"A Phase 2 Study to Evaluate the Safety, Efficacy and PK of Tildacerfont in Children Aged 2-17 Years With CAH","status":"TERMINATED","sponsor":"Spruce Biosciences","startDate":"2021-12-10","conditions":"Congenital Adrenal Hyperplasia, 21-OHD","enrollment":67},{"nctId":"NCT06922669","phase":"NA","title":"Glucocorticoids for Acute Drug Induced Liver Injury With Hyperbilirubinemia","status":"RECRUITING","sponsor":"General Hospital of Shenyang Military Region","startDate":"2025-06-24","conditions":"Drug Induced Liver Injury","enrollment":232},{"nctId":"NCT06387121","phase":"PHASE2","title":"Efficacy and Safety of Low-dose Chemotherapy Plus Immuno-targeted Drugs in Newly Diagnosed Adult Ph- B-ALL","status":"RECRUITING","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2024-04-02","conditions":"Precursor Cell Lymphoblastic Leukemia-Lymphoma","enrollment":53},{"nctId":"NCT07285889","phase":"PHASE1, PHASE2","title":"First-Line Jaktinib for Acute Graft-Versus-Host Disease (aGVHD)","status":"RECRUITING","sponsor":"First Affiliated Hospital of Zhejiang University","startDate":"2025-12-03","conditions":"Acute Graft Versus Host Disease","enrollment":35},{"nctId":"NCT07235904","phase":"PHASE4","title":"Efficacy of Top-down Therapy With Mirikizumab Versus Standard of Care With Azathioprine in Patients With Newly Diagnosed Moderate-to-severe Ulcerative Colitis","status":"RECRUITING","sponsor":"University Hospital Schleswig-Holstein","startDate":"2025-12-05","conditions":"Ulcerative Colitis (UC)","enrollment":300},{"nctId":"NCT05428488","phase":"PHASE3","title":"Efficacy of a Sequential Treatment Strategy in Rheumatoid Arthritis","status":"RECRUITING","sponsor":"University Hospital, Montpellier","startDate":"2022-11-28","conditions":"Rheumatoid Arthritis","enrollment":220},{"nctId":"NCT07010484","phase":"","title":"Using Novel Imaging to Rethink Diagnostic and Treatment Strategies for Polymyalgia Rheumatica","status":"RECRUITING","sponsor":"Kresten Krarup Keller","startDate":"2025-08-21","conditions":"Polymyalgia Rheumatica (PMR)","enrollment":149},{"nctId":"NCT07189910","phase":"PHASE4","title":"Sequential rhTPO and Eltrombopag Following Glucocorticoids for Severe Adult ITP","status":"NOT_YET_RECRUITING","sponsor":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","startDate":"2025-12-01","conditions":"Primary Immune Thrombocytopenia (ITP)","enrollment":150},{"nctId":"NCT05438875","phase":"PHASE3","title":"The Combination of ATRA and Eltrombopag as the Treatment of Steroid-resistant/Relapse ITP Based on MSC-C5b-9","status":"COMPLETED","sponsor":"Peking University People's Hospital","startDate":"2022-10-12","conditions":"Purpura, Thrombocytopenic, Idiopathic","enrollment":96},{"nctId":"NCT07159906","phase":"PHASE1, PHASE2","title":"Homoharringtonine, BCL-2 Inhibitor, Rituximab, and Prednisone in Relapsed/Refractory Diffuse Large B-Cell Lymphoma","status":"NOT_YET_RECRUITING","sponsor":"First Affiliated Hospital of Zhejiang University","startDate":"2025-09-08","conditions":"Diffuse Large B-Cell Lymphoma, Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma","enrollment":62},{"nctId":"NCT07159893","phase":"NA","title":"Inectolizumab With Steroid Optimization in Newly Treated NMOSD","status":"NOT_YET_RECRUITING","sponsor":"First Affiliated Hospital of Wenzhou Medical University","startDate":"2025-09","conditions":"Neuromyelitis Optica, Autoimmune Diseases, Demyelinating Autoimmune Diseases, CNS","enrollment":25},{"nctId":"NCT04308590","phase":"PHASE3","title":"A Study of the Efficacy and Safety of Relacorilant in Patients With Cortisol-Secreting Adrenal Adenomas","status":"COMPLETED","sponsor":"Corcept Therapeutics","startDate":"2020-07-27","conditions":"Hypercortisolism","enrollment":137},{"nctId":"NCT07132398","phase":"PHASE3","title":"Slow vs. Rapid Glucocorticoids Tapering With Inebilizumab in NMOSD","status":"NOT_YET_RECRUITING","sponsor":"Tianjin Medical University General Hospital","startDate":"2025-09-01","conditions":"Neuromyelitis Optica (NMO), Neuromyelitis Optica Spectrum Disorders (NMOSD)","enrollment":170},{"nctId":"NCT03126110","phase":"PHASE1, PHASE2","title":"Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic Malignancies","status":"COMPLETED","sponsor":"Incyte Biosciences International Sàrl","startDate":"2017-04-25","conditions":"Advanced Malignancies, Metastatic Cancer","enrollment":145},{"nctId":"NCT05660473","phase":"PHASE2","title":"Pediatric-inspired Regimen Combined With Venetoclax for Adolescent and Adult Patients With de Novo Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia","status":"RECRUITING","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2022-08-01","conditions":"Precursor Cell Lymphoblastic Leukemia-Lymphoma","enrollment":100},{"nctId":"NCT06867991","phase":"PHASE3","title":"Safety and Efficacy of Combined B Cell Depleting theRapy And Daratumumab In Autoimmune Encephalitis","status":"RECRUITING","sponsor":"The First People's Hospital of Changzhou","startDate":"2024-11-08","conditions":"Anti-N-Methyl-D-Aspartate Receptor Encephalitis","enrollment":200},{"nctId":"NCT07059156","phase":"PHASE2, PHASE3","title":"Multicenter Study of Combined Chemotherapy and Transplantation for Adult ALL","status":"RECRUITING","sponsor":"Shanxi Bethune Hospital","startDate":"2025-06-01","conditions":"Acute Lymphoblastic Leukemia, Adult","enrollment":50},{"nctId":"NCT06881290","phase":"PHASE1","title":"Vunakizumab for the Treatment of Mild to Moderate Systemic Lupus Erythematosus","status":"RECRUITING","sponsor":"Chinese SLE Treatment And Research Group","startDate":"2025-05-19","conditions":"Lupus Erythematosus, Systemic","enrollment":20},{"nctId":"NCT03542279","phase":"NA","title":"CPI Combination Therapy for Autoimmune Encephalitis","status":"COMPLETED","sponsor":"Xuanwu Hospital, Beijing","startDate":"2020-11-25","conditions":"Autoimmune Encephalitis","enrollment":70},{"nctId":"NCT07021950","phase":"PHASE2","title":"AK112 Plus FOLFIRI Versus Bevacizumab Plus FOLFIRI as Second-line Treatment of MSS/pMMR Metastatic Colorectal Cancer","status":"NOT_YET_RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2025-08-10","conditions":"Colorectal Cancer, Ivonescimab","enrollment":130},{"nctId":"NCT04848493","phase":"","title":"National Project on Vaccines, COVID-19 and Frail Patients","status":"COMPLETED","sponsor":"Azienda USL Reggio Emilia - IRCCS","startDate":"2021-04-19","conditions":"COVID-19, Solid Tumor, Hematologic Diseases","enrollment":747},{"nctId":"NCT06607016","phase":"PHASE2","title":"A Clinical Trial With KJ103 in Anti-GBM Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"Shanghai Bao Pharmaceuticals Co., Ltd.","startDate":"2024-10-21","conditions":"Anti-Glomerular Basement Membrane Disease","enrollment":12},{"nctId":"NCT00001521","phase":"PHASE3","title":"Three Drug Combination Therapy Versus Conventional Treatment of Children With Congenital Adrenal Hyperplasia","status":"COMPLETED","sponsor":"Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","startDate":"1995-06-08","conditions":"Congenital Adrenal Hyperplasia (CAH)","enrollment":66},{"nctId":"NCT06992128","phase":"PHASE2","title":"Romiplostim N01 Combined With Glucocorticoids as the First-line Treatment for Newly Diagnosed Adult Primary Immune Thrombocytopenia: A Multicenter, Interventional Trial","status":"RECRUITING","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2025-05-22","conditions":"Primary Immune Thrombocytopenia (ITP)","enrollment":129},{"nctId":"NCT06957002","phase":"PHASE2","title":"Bosentan in the Treatment of Giant Cell Arteritis","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2025-09","conditions":"Giant Cell Arteritis (GCA)","enrollment":40},{"nctId":"NCT05998759","phase":"PHASE2","title":"Telitacicept for the Treatment of Connective Tissue Disease-associated Thrombocytopenia","status":"RECRUITING","sponsor":"Beijing Hospital","startDate":"2023-12-02","conditions":"Connective Tissue Diseases, Thrombocytopenia","enrollment":296},{"nctId":"NCT06611696","phase":"PHASE4","title":"Avacopan vs Reduced-dose Glucocorticoids in ANCA-associated Vasculitis","status":"RECRUITING","sponsor":"Chiba University","startDate":"2024-11-15","conditions":"ANCA Associated Vasculitis (AAV)","enrollment":160},{"nctId":"NCT02378298","phase":"PHASE4","title":"Rituximab (RTX) Therapy in Patients With Active TAO","status":"COMPLETED","sponsor":"Göteborg University","startDate":"2011-12","conditions":"Ophthalmopathy, Thyroid-Associated","enrollment":38},{"nctId":"NCT05329090","phase":"PHASE3","title":"Evaluation of Glucocorticoids Plus Rituximab in Patients with Newly-Diagnosed or Relapsing IgA Vasculitis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hopital Foch","startDate":"2022-03-11","conditions":"IgA Vasculitis","enrollment":75},{"nctId":"NCT06854380","phase":"EARLY_PHASE1","title":"Effect of Intralesional Injection of Corticosteroids Combined with Hyaluronidase in Treatment of Minimal Associated Pathological Lesions of Vocal Folds, Participants and Condition: Patients with Benign Vocal Fold Lesions, Intervention: Intralesional Injection Via Working Channel of Nasofiberscope","status":"RECRUITING","sponsor":"Mansoura University","startDate":"2026-01-01","conditions":"Voice and Voice Disorders","enrollment":20},{"nctId":"NCT06686927","phase":"PHASE2","title":"Study on Glucocorticoid Combined With Gamma Globulin and Ropristine N01 in Treatment of Initial Severe ITP","status":"RECRUITING","sponsor":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","startDate":"2024-11-20","conditions":"Primary Immune Thrombocytopenia","enrollment":36},{"nctId":"NCT06772454","phase":"","title":"To Evaluate the Efficacy and Safety of Inhaled Corticosteroids Combined With Bronchodilators and Programmed Death-ligand 1 (PD-L1) Inhibitor Plus Platinum-based Chemotherapy in Patients With Advanced Lung Squamous Cell Carcinoma Complicated With Chronic Obstructive Pulmonary Disease (COPD)","status":"RECRUITING","sponsor":"Guangzhou Institute of Respiratory Disease","startDate":"2023-01-01","conditions":"Lung Cancer Squamous Cell, COPD","enrollment":60},{"nctId":"NCT06754267","phase":"PHASE2","title":"Venetoclax Combined With Olverembatinib and Predinisone in Treating Ph+ B-ALL","status":"RECRUITING","sponsor":"First Affiliated Hospital of Zhejiang University","startDate":"2024-12","conditions":"Precursor B-Cell Acute Lymphoblastic Leukemia","enrollment":36},{"nctId":"NCT06730308","phase":"PHASE2","title":"Glucocorticoids Combined With Concurrent Chemoradiotherapy for Unresectable Thymoma","status":"RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2024-11-20","conditions":"Thymoma","enrollment":45},{"nctId":"NCT05714670","phase":"PHASE2","title":"The Effect of Curcumin on the Clinical Outcome of Pediatric Patients with Active Lupus Nephritis","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2023-04-01","conditions":"Lupus Nephritis, SLE Nephritis","enrollment":72},{"nctId":"NCT06663618","phase":"NA","title":"Short-term Glucocorticoid Combined with MMF for IgG4-RD","status":"RECRUITING","sponsor":"Wen Zhang","startDate":"2023-09-01","conditions":"IgG4-related Disease","enrollment":63},{"nctId":"NCT06663943","phase":"PHASE1, PHASE2","title":"A Randomized Study on Pemphigus Treatment With Humanized CD38 Antibody CM313.","status":"NOT_YET_RECRUITING","sponsor":"Chao Ji","startDate":"2025-10-01","conditions":"Pemphigus Disease, Pemphigus Vulgaris (PV)","enrollment":100},{"nctId":"NCT06658834","phase":"PHASE2","title":"A Study of Romiplostim N01 as the First-line Treatment for Newly Diagnosed Adult Patients With ITP","status":"RECRUITING","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2024-06-01","conditions":"Primary Immune Thrombocytopenia","enrollment":129},{"nctId":"NCT06498089","phase":"PHASE4","title":"A Randomized, Controlled, Open-label, Multicenter Clinical Trial Comparing the Efficacy and Safety of a Precision Treatment Regimen Based on Clinical-molecular Phenotypes with a Conventional Treatment Regimen in the Treatment of Patients with Active Takayasu's Arteritis","status":"RECRUITING","sponsor":"Shanghai Zhongshan Hospital","startDate":"2024-06-28","conditions":"Takayasu Arteritis","enrollment":124},{"nctId":"NCT06498180","phase":"NA","title":"Periodontal Initial Treatment Combined With Glucocorticoid Therapy for Erosive Oral Lichen Planus","status":"NOT_YET_RECRUITING","sponsor":"Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University","startDate":"2024-12-31","conditions":"Oral Lichen Planus, Periodontal Diseases","enrollment":29},{"nctId":"NCT05916781","phase":"PHASE4","title":"Effectiveness of Mycophenolate Mofetil Combined With Tacrolimus for Steroid Tapering in Systemic Lupus Erythematosus","status":"RECRUITING","sponsor":"Chinese SLE Treatment And Research Group","startDate":"2023-07-01","conditions":"Systemic Lupus Erythematosus, Lupus Nephritis","enrollment":220},{"nctId":"NCT05592717","phase":"","title":"A Study of YUTIQ® 0.18 mg Intravitreal Implant for the Management of Chronic Non-infectious Uveitis","status":"RECRUITING","sponsor":"Tianjin Medical University","startDate":"2023-01-05","conditions":"Uveitis, YUTIQ","enrollment":15},{"nctId":"NCT04915482","phase":"PHASE2, PHASE3","title":"TPO-RAs Combined With Anti-CD20 Antibody in the Treatment of Adult Immune Thrombocytopenia With Autoantibodies","status":"RECRUITING","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2021-06-06","conditions":"Immune Thrombocytopenia (ITP), Autoantibodies, Evan Syndrome","enrollment":94},{"nctId":"NCT05590416","phase":"","title":"A Study of Adalimumab in Acute Vogt-Koyanagi-Harada Disease","status":"RECRUITING","sponsor":"Tianjin Medical University","startDate":"2021-06-01","conditions":"Vogt-Koyanagi-Harada Disease, Adalimumab","enrollment":15},{"nctId":"NCT06473909","phase":"PHASE2","title":"Combination of Steroid and Humanized CD25 Monoclonal Antibody as First-line Therapy for aGVHD","status":"NOT_YET_RECRUITING","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2024-07-01","conditions":"Acute Graft Versus Host Disease","enrollment":20},{"nctId":"NCT06468709","phase":"PHASE4","title":"A Trial on the Recurrence Free Survival Rate of Type I AIP With High-risk of Recurrence","status":"RECRUITING","sponsor":"Ruijin Hospital","startDate":"2024-06-20","conditions":"Type 1 AIP","enrollment":86},{"nctId":"NCT05514015","phase":"PHASE4","title":"Clinical Study of Rituximab Combined With Corticosteroids or Rituximab Monotherapy in the Treatment of Primary Membranous Nephropathy","status":"RECRUITING","sponsor":"First Affiliated Hospital, Sun Yat-Sen University","startDate":"2024-03-29","conditions":"Primary Membranous Nephropathy","enrollment":78},{"nctId":"NCT05370547","phase":"PHASE1, PHASE2","title":"Chidamide Bridging for CAR-T Therapy","status":"RECRUITING","sponsor":"Chinese PLA General Hospital","startDate":"2022-05-25","conditions":"Non Hodgkin's Lymphoma","enrollment":120},{"nctId":"NCT04373265","phase":"PHASE1","title":"Study of Relacorilant in Combination With Pembrolizumab for Patients With Adrenocortical Carcinoma Which Produces Too Much Stress Hormone (Cortisol)","status":"COMPLETED","sponsor":"Corcept Therapeutics","startDate":"2020-09-30","conditions":"Adrenocortical Carcinoma","enrollment":15},{"nctId":"NCT05444946","phase":"NA","title":"Oral Itraconazole Versus Combination of Systemic Glucorticoids and Oral Itraconazole in CPA-ABPA Overlap Syndrome","status":"UNKNOWN","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2022-06-15","conditions":"Chronic Pulmonary Aspergillosis, Allergic Bronchopulmonary Aspergillosis","enrollment":104},{"nctId":"NCT05666336","phase":"PHASE4","title":"Multi-omics Studies on the Efficacy of Telitacicept in Chinese SLE Patients","status":"UNKNOWN","sponsor":"Fen Li","startDate":"2022-12-31","conditions":"Systemic Lupus Erythematosus","enrollment":30},{"nctId":"NCT03928314","phase":"PHASE1","title":"Study of ORIC-101 in Combination With Anticancer Therapy","status":"TERMINATED","sponsor":"ORIC Pharmaceuticals","startDate":"2019-05-02","conditions":"Solid Tumor","enrollment":83},{"nctId":"NCT06167174","phase":"","title":"Exploring Biomarkers for Therapeutic Response of Lupus Nephritis Based on Multi Omics Analysis","status":"RECRUITING","sponsor":"Chinese SLE Treatment And Research Group","startDate":"2023-12-05","conditions":"Lupus Nephritis","enrollment":100},{"nctId":"NCT05627739","phase":"","title":"A Study of Mycophenolate Mofetil Combined With Glucocorticoid Therapy in Relapse Vogt-Koyanagi-Harada Disease","status":"UNKNOWN","sponsor":"Tianjin Medical University","startDate":"2021-10-01","conditions":"Vogt-Koyanagi-Harada Disease, Mycophenolate Mofetil","enrollment":15},{"nctId":"NCT05405439","phase":"PHASE1, PHASE2","title":"To Evaluate the Efficacy of TQB3823 Combined With Abiraterone and Prednisone in Metastatic Castration-resistant Prostate Cancer Patientsprednisone Acetate Tablets in Patients With Metastatic Castration-resistant Prostate Cancer","status":"TERMINATED","sponsor":"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.","startDate":"2022-08-25","conditions":"Metastatic Castration-resistant Prostate Cancer","enrollment":39},{"nctId":"NCT03821714","phase":"NA","title":"Effects of Glucocorticoid Combined With Vitamin C and Vitamin B1 on Microcirculation in Severe Septic Shock","status":"COMPLETED","sponsor":"Southeast University, China","startDate":"2019-02-01","conditions":"Septic Shock","enrollment":22},{"nctId":"NCT06066840","phase":"PHASE4","title":"Vedolizumab, Anti-CD25 Antibody, Rapid Reduction of Glucocorticoids for SR-aGVHD With Gastrointestinal Involvement","status":"UNKNOWN","sponsor":"The First Affiliated Hospital of Soochow University","startDate":"2022-08-01","conditions":"Safety and Efficacy","enrollment":45},{"nctId":"NCT03096275","phase":"PHASE3","title":"Comparison of Mycophenolate Mofetil and Cyclophosphamide for Active Takayasu's Arteritis","status":"COMPLETED","sponsor":"Chinese SLE Treatment And Research Group","startDate":"2017-03-16","conditions":"Takayasu Arteritis","enrollment":138},{"nctId":"NCT05969522","phase":"PHASE4","title":"Stratified Therapy on Pediatric AAGN","status":"UNKNOWN","sponsor":"Wang Mo","startDate":"2023-01-01","conditions":"Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, ANCA-Associated Glomerulonephritis","enrollment":200},{"nctId":"NCT05962840","phase":"PHASE4","title":"Efficacy and Safety for Rituximab Combined With Telitacicept in the Treatment of ANCA-associated Vasculitis (TTCAAVREM)","status":"RECRUITING","sponsor":"Chinese SLE Treatment And Research Group","startDate":"2023-06-29","conditions":"ANCA Associated Vasculitis","enrollment":40},{"nctId":"NCT05855395","phase":"NA","title":"The Standard of Care Combined With Glucocorticoid in Elderly People With Mild or Moderate COVID-19","status":"UNKNOWN","sponsor":"Huashan Hospital","startDate":"2023-05-26","conditions":"COVID-19","enrollment":5815},{"nctId":"NCT03437941","phase":"PHASE1, PHASE2","title":"Study to Evaluate CORT125281 in Combination With Enzalutamide in Patients With mCRPC","status":"COMPLETED","sponsor":"Corcept Therapeutics","startDate":"2017-12-15","conditions":"Metastatic Castration-Resistant Prostate Cancer","enrollment":39},{"nctId":"NCT00005585","phase":"PHASE3","title":"Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2000-04","conditions":"Leukemia","enrollment":838},{"nctId":"NCT05746689","phase":"NA","title":"Study of Sirolimus in IgG4-related Disease","status":"NOT_YET_RECRUITING","sponsor":"Peking University International Hospital","startDate":"2023-03-01","conditions":"IgG4-related Disease","enrollment":20},{"nctId":"NCT05682586","phase":"PHASE3","title":"UC-MSCs in the Treatment of Severe and Critical COVID-19 Patients","status":"UNKNOWN","sponsor":"Shanghai East Hospital","startDate":"2023-01-09","conditions":"Mesenchymal Stem Cell, COVID-19 Pneumonia","enrollment":60},{"nctId":"NCT05658692","phase":"PHASE4","title":"Platform Adaptive Embedded Trial for Acute Respiratory Distress Syndrome","status":"UNKNOWN","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2022-10-01","conditions":"Acute Respiratory Distress Syndrome","enrollment":1000},{"nctId":"NCT05625581","phase":"","title":"Tofatib Treatment for IgG4-related Disease","status":"UNKNOWN","sponsor":"Changhai Hospital","startDate":"2022-11-10","conditions":"IgG4-related Disease","enrollment":40},{"nctId":"NCT01680965","phase":"PHASE1, PHASE2","title":"Ofatumumab as Primary Therapy of Chronic Graft Versus Host Disease","status":"COMPLETED","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2012-11-14","conditions":"Chronic Graft Versus Host Disease","enrollment":44},{"nctId":"NCT05532111","phase":"NA","title":"Efficacy and Safety of the Treatment of Primary Membranous Nephropathy: A Randomized Clinical Trial","status":"UNKNOWN","sponsor":"RenJi Hospital","startDate":"2022-09-01","conditions":"Efficacy and Safety","enrollment":60},{"nctId":"NCT05531266","phase":"NA","title":"Umbilical Cord Mesenchymal Stem Cells as First-line Treatment for Patients With Acute Graft Versus Host Disease","status":"UNKNOWN","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2022-09-01","conditions":"aGVHD","enrollment":182},{"nctId":"NCT05439577","phase":"","title":"A Multicentre Study to Explore the Efficacy and Safety of Mucopolysaccharide Polysulfate Cream in Patients With Eczema","status":"UNKNOWN","sponsor":"Shenzhen Kangzhe Pharmaceutical Co., Ltd.","startDate":"2021-09-23","conditions":"Eczema","enrollment":1800},{"nctId":"NCT03449459","phase":"EARLY_PHASE1","title":"Prevention of Acute Exacerbation in Subjects With COPD by Bacterial Decolonization in Lower Respiratory Tract","status":"COMPLETED","sponsor":"Shanghai Zhongshan Hospital","startDate":"2018-12-01","conditions":"Chronic Obstructive Pulmonary Disease (COPD)","enrollment":144},{"nctId":"NCT04335305","phase":"PHASE2","title":"Checkpoint Blockade in COVID-19 Pandemic","status":"TERMINATED","sponsor":"MedSIR","startDate":"2020-04-09","conditions":"COVID-19, Pneumonia, Viral","enrollment":12},{"nctId":"NCT05375435","phase":"PHASE4","title":"Efficacy and Safety of Triple Therapy in Patients With Anti-MDA5 Antibody-positive Dermatomyositis","status":"UNKNOWN","sponsor":"The First Affiliated Hospital with Nanjing Medical University","startDate":"2022-01-01","conditions":"Dermatomyositis, Adult Type, Interstitial Lung Disease","enrollment":120},{"nctId":"NCT05374850","phase":"","title":"Impact of Cervical Parameters to Interlaminar Epidural Steroid Injection Treatment Outcomes in Patients With Cervical Disc Herniation","status":"UNKNOWN","sponsor":"Marmara University","startDate":"2022-06","conditions":"Cervical Disc Herniation","enrollment":60},{"nctId":"NCT03525028","phase":"NA","title":"A Clinical Trial of Metformin to Decrease Glucocorticoids Side Effects in Patients With Autoimmune Uveitis","status":"UNKNOWN","sponsor":"Tianjin Medical University","startDate":"2018-11-01","conditions":"Uveitis, Metformin, Glucocorticoid","enrollment":138},{"nctId":"NCT03466801","phase":"NA","title":"The Efficacy of Prednisone and Combination Therapy With Methylprednisolone and Cyclophosphamide on IMN in Stage I.","status":"TERMINATED","sponsor":"Wenhu Liu","startDate":"2018-03-20","conditions":"Idiopathic Membranous Nephropathy","enrollment":6},{"nctId":"NCT04124861","phase":"NA","title":"Withdraw Drug in Stable IgG4-Related Disease","status":"UNKNOWN","sponsor":"Peking Union Medical College Hospital","startDate":"2020-06-23","conditions":"Autoimmune Diseases","enrollment":138},{"nctId":"NCT02930343","phase":"PHASE3","title":"Comparison of Disease Modifying Antirheumatic Drugs Therapy in Patients With RA Failing Methotrexate Monotherapy","status":"TERMINATED","sponsor":"Jawaharlal Institute of Postgraduate Medical Education & Research","startDate":"2016-09","conditions":"Rheumatoid Arthritis","enrollment":136},{"nctId":"NCT03277352","phase":"PHASE1, PHASE2","title":"INCAGN01876 in Combination With Immune Therapies in Subjects With Advanced or Metastatic Malignancies","status":"TERMINATED","sponsor":"Incyte Biosciences International Sàrl","startDate":"2017-11-21","conditions":"Advanced Malignancies, Metastatic Cancer","enrollment":10},{"nctId":"NCT04966884","phase":"PHASE4","title":"The Efficacy and Safety of JAK Inhibitor in the Treatment of Anti-MDA5 Antibody-positive Dermatomyositis Patients","status":"UNKNOWN","sponsor":"First Affiliated Hospital Xi'an Jiaotong University","startDate":"2020-04-02","conditions":"Dermatomyositis, Adult Type","enrollment":20},{"nctId":"NCT04946669","phase":"EARLY_PHASE1","title":"An Exploratory Study on the Efficacy and Safety of Abatacept in the Treatment of Refractory Dermatomyositis","status":"UNKNOWN","sponsor":"The First Affiliated Hospital with Nanjing Medical University","startDate":"2021-02-01","conditions":"Dermatomyositis, Abatacept","enrollment":20},{"nctId":"NCT04927000","phase":"PHASE4","title":"The Role of Tofacitinib in Steroid Withdrawal in Rheumatoid Arthritis","status":"UNKNOWN","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2021-05-31","conditions":"Rheumatoid Arthritis","enrollment":170},{"nctId":"NCT04617561","phase":"PHASE4","title":"Ursodeoxycholic Acid Combined With Low Dose Glucocorticoid in the Treatment of PBC With AIH Features II","status":"UNKNOWN","sponsor":"West China Hospital","startDate":"2020-11-01","conditions":"Hepatitis, Autoimmune, Primary Biliary Cholangitis","enrollment":90},{"nctId":"NCT04023149","phase":"PHASE2","title":"Efficacy of Interleukin-2 Gargle in the Treatment of Oral Mucosa Lesion in Pemphigus Vulgaris","status":"UNKNOWN","sponsor":"Second Xiangya Hospital of Central South University","startDate":"2020-04-02","conditions":"Pemphigus Vulgaris","enrollment":180},{"nctId":"NCT04660565","phase":"PHASE4","title":"Belimumab Treatment for IgG4-related Disease","status":"UNKNOWN","sponsor":"Peking Union Medical College Hospital","startDate":"2021-01","conditions":"IgG4-related Disease","enrollment":60},{"nctId":"NCT04479202","phase":"PHASE4","title":"The Effect of Berberine on Intestinal Function and Inflammatory Mediators in Severe Patients With Covid-19","status":"COMPLETED","sponsor":"Chinese Medical Association","startDate":"2020-02-08","conditions":"Berberine, COVID-19","enrollment":76}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":6,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Hydrocortisone, vitamin C and vitamin B1","Dexamethasone","Hydrocortisone"],"phase":"marketed","status":"active","brandName":"Glucocorticoid combination therapy","genericName":"Glucocorticoid combination therapy","companyName":"Southeast University, China","companyId":"southeast-university-china","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Glucocorticoid combination therapy suppresses immune and inflammatory responses by binding to glucocorticoid receptors and modulating cytokine production and immune cell activation. Used for Inflammatory and autoimmune diseases (specific indications not detailed in available information).","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}